Roger Chang

Roger Chang is a physician-scientist with expertise in epilepsy, electrophysiology, and neuromodulation, dedicated to developing innovative therapeutics for refractory epilepsy. They completed their Doctor of Medicine (MD) and Doctor of Philosophy (PhD) in Biomedical Sciences at the University of California, San Francisco, as well as a Bachelor of Science in Biomedical Engineering at Washington University in St. Louis. Roger has held positions as a Graduate Student and Staff Research Associate II at UCSF, a Resident Physician at the University of Washington, and is currently an Associate Medical Director at Arrowhead Pharmaceuticals. They will serve as a Clinical Instructor and Epilepsy Fellow at Stanford University School of Medicine in the near future.